Is LMP Capital and Income Fund Inc. (SCD) a Buy, Sell, or Hold?
NYSE : SCD
LMP Capital and Income Fund Inc.
$15.3 USD
-$0.14 (-0.91%)
- Volume
- 156.76K
- Average Volume
- 64.95K
- Market Capitalization
- $5.13B
- P/E Ratio
- -31.22
- Dividend Yield
- 9.41%
- Price Target
- Year High
- $16.18
- Year Low
- $13.79
- Day High
- —
- Day Low
- —
- Payout Ratio
- -$32.78
- Current Ratio
- $0.28
Company Overview
NYSE
Kenneth Donald Fuller
Asset Management - Income
Financial Services
SCD
N/A
US
USD
212-805-2000
50208A102
0001270131
Liquidity Metrics
0.21
0.28
0.28
0.00
-32.78
Sales & Valuation
$54.77M
652.91
0.93
339.32
0.66
Profitability
-$0.0358
-$820.21K
-10.45%
-10.45%
-0.25%
-0.18%
P/E Metrics
-31.22
0.29
0.29
Analyst Price Target & Rating
2/5
0 Analysts
%
Poll Results
About LMP Capital and Income Fund Inc. (NYSE:SCD) Stock
The LMP Capital and Income Fund Inc. operates as a closed-end balanced mutual fund, primarily overseen by Legg Mason Partners Fund Advisor, LLC. Additional management responsibilities are shared with Clearbridge Investments, LLC, Western Asset Management Company Limited, and Western Asset Management Company. Its investment mandate extends globally, encompassing both public equity and fixed-income securities from businesses spanning various sectors. Key holdings include shares of large-capitalization firms, corporate bonds and notes of intermediate maturity with a minimum A- rating, both energy and non-energy master limited partnerships (MLPs), and real estate investment trusts (REITs). Portfolio construction is heavily influenced by a rigorous analysis of economic, market, and political la ... ndscapes, as well as fiscal and monetary policies, alongside thorough security valuation. Its performance is measured against two standard benchmarks: the U.S. Aggregate Index and the S&P 500 Index. Established in the United States on November 12, 2003, it was previously recognized as the Salomon Brothers Capital and Income Fund Inc.
2026-07-16 07:30:00
Galmed has developed, in collaboration with Barcode Nanotech, a unique proprietary lipid nanoparticles (LPNs) novel formulation of Aramchol that penetrates the heart tissue and redirects Aramchol's biodistribution away from liver-hepatocytes to the heart's muscle. Cardiac fibrosis is a major driver of chronic heart failure, the leading cause of death globally, responsible for an estimated 20.5 million deaths in 2025.
10 Best CEFs This Month: Average Yield Of Near 10% (June 2026)
2026-06-27 08:15:00
The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9.8% plus yield and nearly 7.5% NAV discount. Selections emphasize sector diversification, long-term outperformance, sustainable distributions, and attractive valuations, with a focus on both equity and credit-oriented CEFs. CEFs are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone.
SCD: Gets The Job Done But Not The Most Efficient Income Fund
2026-06-18 02:42:46
LMP Capital and Income Fund maintains a 9.2% yield, with management expressing confidence in sustaining current distributions through August. Recent performance and distribution consistency have been concerns, leading to a hold rating on SCD. Franklin Templeton's management strategy and risk profile are key considerations for SCD's forward outlook.
2026-06-11 03:00:00
[url="]Vertex Pharmaceuticals Incorporated[/url] (Nasdaq: VRTX) today announced data demonstrating the clinical benefits of CASGEVYÂ (exagamglogene autotemcel
10 Best CEFs This Month: Average Yield Of 9% Plus (May 2026)
2026-05-23 08:30:00
The article presents a rigorously screened list of 10 top closed-end funds, or CEFs, for income investors, offering an average 9% plus yield and nearly 7.5% NAV discount. Selections emphasize sector diversification, long-term outperformance, sustainable distributions, and attractive valuations, with a focus on both equity and credit-oriented CEFs. CEFs are generally characterized by higher volatility and deeper drawdowns than the broader market. For these reasons, they are not suited for everyone.
Emmaus Life Sciences Reports Quarterly Financial Results
2026-05-15 16:00:00
Emmaus Life Sciences, Inc. (OTCQB: EMMA),a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, today reported on its
Frequently Asked Questions
-
What is the current LMP Capital and Income Fund Inc. (SCD) stock price?
-
LMP Capital and Income Fund Inc.(NYSE:SCD) stock price is $15.3 in the last trading session. During the trading session, SCD stock reached the peak price of $16.18 while $13.79 was the lowest point it dropped to. The percentage change in SCD stock occurred in the recent session was --0.91% while the dollar amount for the price change in SCD stock was -$0.14.
-
SCD's industry and sector of operation?
-
The NYSE listed SCD is part of Asset Management - Income industry that operates in the broader Financial Services sector.
-
Who are the executives of SCD?
-
Kenneth Donald Fuller | Chairman, Chief Executive Officer and President
Peter J. Vanderlee | Portfolio Manager
Harry David Cohen | Portfolio Manager
|
| -
How many employees does SCD have?
-
Number of SCD employees currently stands at None. SCD operates from 620 Eighth Avenue, New York City, NY 10018, US.
-
Link for SCD official website?
-
How do I contact SCD?
-
SCD could be contacted at phone #212-805-2000 and can also be accessed through its website. SCD operates from 620 Eighth Avenue, New York City, NY 10018, US.
-
How many shares of SCD are traded daily?
-
The average number of SCD shares traded daily for last 3 months was 64.95K.
-
What is the market cap of SCD currently?
-
The market value of SCD currently stands at $5.13B with its latest stock price at $15.3